TPMT and acute lymphoblastic leukemia: Table 1 describes the clinical characteristics of 320 pediatric patients with ALL according to their PGx subgroups, presenting 80 patients who were non-WTs (i.e., IMs or PMs) of NUDT15 and/or TPMT (N = 80), 115 patients who were all WTs (WT carriers of all the four genes), and 125 who were WTs of both genes, NUDT15 and TPMT (both WTs) and carried CRIM1 rs3821169 and/or IL6 rs13306435 variants.